2,196
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS

, , , , , , , , , & show all
Pages 1-10 | Received 23 Mar 2018, Accepted 03 Jul 2018, Published online: 31 Jul 2018

References

  • DragulescuECCoditaIHost-pathogen interaction in infections due to staphylococcus aureus. staphylococcus aureus virulence factorsRoum. Arch. Microbiol Immunol.201574 46 64
  • OkesolaAOCommunity-acquired methicillin-resistant Staphylococcus aureus--a review of literatureAfr. J. Med. Med. Sci.20114097107
  • SeilieESBubeck WardenburgJStaphylococcus aureus pore-forming toxins: the interface of pathogen and host complexitySemin. Cell Dev. Biol.20177210111610.1016/j.semcdb.2017.04.003
  • BhakdiSTranum-JensenJAlpha-toxin of Staphylococcus aureusMicrobiol. Rev.199155733751372845
  • NygaardTKAlpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infectionPLoS ONE20127e3653210.1371/journal.pone.00365323344897
  • PowersMEKimHKWangYBubeck WardenburgJADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysinJ. Infect. Dis.201220635235610.1093/infdis/jis1923392186
  • CassidyPSHarshmanSThe binding of staphylococcal 125I-alpha-toxin (B) to erythrocytesJ. Biol. Chem.197324855455546
  • KebaierCStaphylococcus aureus alpha-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasomeJ. Infect. Dis.201220580781710.1093/infdis/jir8463274379
  • AggarwalBBRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res.2004245A27832840
  • ChanMMYAntimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skinBiochem. Pharmacol.2002639910410.1016/S0006-2952(01)00886-3
  • UdenigweCCRamprasathVRAlukoREJonesPJPotential of resveratrol in anticancer and anti-inflammatory therapyNutr. Rev.20086644545410.1111/j.1753-4887.2008.00076.x
  • ZhaoYTangHZengXYeDLiuJResveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cellsBiomed. Pharmacother.201898364410.1016/j.biopha.2017.12.029
  • CarlsonAAnticancer effects of resveratrol in canine hemangiosarcoma cell linesVet. Comp. Oncol.20171625326110.1111/vco.12375
  • PauloLFerreiraSGallardoEQueirozJADominguesFAntimicrobial activity and effects of resveratrol on human pathogenic bacteriaWorld J. Microbiol. Biotechnol.2010261533153810.1007/s11274-010-0325-7
  • MainieroMDifferential target gene activation by the Staphylococcus aureus two-component system saeRSJ. Bacteriol.201019261362310.1128/JB.01242-09
  • LiuQYeoWSBaeTThe SaeRS two-component system of Staphylococcus aureusGenes (Basel)201681
  • XiongYQWillardJYeamanMRCheungALBayerASRegulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditisJ. Infect. Dis.20061941267127510.1086/508210
  • RogaschKInfluence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strainsJ. Bacteriol.20061887742775810.1128/JB.00555-061636327
  • BesserJCarletonHAGerner-SmidtPLindseyRLTreesENext-generation sequencing technologies and their application to the study and control of bacterial infectionsClin. Microbiol Infect.20172335341
  • PintoACMelo-BarbosaHPMiyoshiASilvaAAzevedoVApplication of RNA-seq to reveal the transcript profile in bacteriaGenet Mol. Res.2011101707171810.4238/vol10-3gmr1554
  • PlanetPJLife after USA300: the rise and fall of a superbugJ. Infect. Dis.2017215Suppl 1S71S7710.1093/infdis/jiw4445853207
  • LiVEmergence of new CMRSA7/USA400 methicillin-resistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012J. Clin. Microbiol2014522439244610.1128/JCM.00505-144097756
  • SmythDSPopulation structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-IIIPLoS ONE20105e858210.1371/journal.pone.00085822797301
  • GniadkowskiMEvolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganismsClin. Microbiol. Infect.2001759760810.1046/j.1198-743x.2001.00330.x
  • HooperDCJacobyGAMechanisms of drug resistance: quinolone resistanceAnn. New Y. Acad. Sci.20151354123110.1111/nyas.12830
  • GuptaAKLyonsDCRosenTNew and emerging concepts in managing and preventing community-associated methicillin-resistant Staphylococcus aureus infectionsInt J. Dermatol.2015541226123210.1111/ijd.13010
  • MontgomeryCPBoyle-VavraSDaumRSImportance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infectionPLoS ONE20105e1517710.1371/journal.pone.00151772996312
  • AdhikariRPNovickRPRegulatory organization of the staphylococcal sae locusMicrobiology2008154Pt 394995910.1099/mic.0.2007/012245-0
  • Clinical and Laboratory Standard Institute. M100Performance Standards for Antimicrobial Susceptibility Testing 28th edn, (Clinical and Laboratory Standards Institute: Wayne, PA, 2018.
  • LiM“MRSA epidemic linked to a quickly spreading colonization and virulence determinantNat. Med.20121881681910.1038/nm.26923378817